192 related articles for article (PubMed ID: 17445545)
1. Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma.
Ermetici F; Malavazos AE; Corbetta S; Morricone L; Dall'Asta C; Corsi MM; Ambrosi B
Metabolism; 2007 May; 56(5):686-92. PubMed ID: 17445545
[TBL] [Abstract][Full Text] [Related]
2. Insulin sensitivity and related cytokines, chemokines, and adipokines in polymyalgia rheumatica.
Kreiner F; Galbo H
Scand J Rheumatol; 2010; 39(5):402-8. PubMed ID: 20615159
[TBL] [Abstract][Full Text] [Related]
3. Plasma and salivary 6beta-hydroxycortisol measurements for assessing adrenocortical activity in patients with adrenocortical adenomas.
Varga I; Jakab C; Szücs N; Patócs A; Tóth M; Kiss R; Gláz E; Rácz K
Horm Metab Res; 2003 Jul; 35(7):421-6. PubMed ID: 12931273
[TBL] [Abstract][Full Text] [Related]
4. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).
Krawczyk K; Szczesniak P; Kumor A; Jasinska A; Omulecka A; Pietruczuk M; Orszulak-Michalak D; Sporny S; Malecka-Panas E
J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():71-5. PubMed ID: 19996485
[TBL] [Abstract][Full Text] [Related]
5. Increased levels of tumour necrosis factor-alpha (TNF-alpha) in patients with Type II diabetes mellitus after myocardial infarction are related to endothelial dysfunction.
Nyström T; Nygren A; Sjöholm A
Clin Sci (Lond); 2006 Jun; 110(6):673-81. PubMed ID: 16466346
[TBL] [Abstract][Full Text] [Related]
6. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance.
Monzillo LU; Hamdy O; Horton ES; Ledbury S; Mullooly C; Jarema C; Porter S; Ovalle K; Moussa A; Mantzoros CS
Obes Res; 2003 Sep; 11(9):1048-54. PubMed ID: 12972674
[TBL] [Abstract][Full Text] [Related]
7. [Selected cytokines (Il-6, Il-8, Il-10, MCP-1, TNF-alpha) in children and adolescents with atherosclerosis risk factors: obesity, hypertension, diabetes].
Głowińska B; Urban M
Wiad Lek; 2003; 56(3-4):109-16. PubMed ID: 12923954
[TBL] [Abstract][Full Text] [Related]
8. Adipokine and cytokine levels in non-functioning adrenal incidentalomas (NFAI).
Babinska A; Kaszubowski M; Sworczak K
Endocr J; 2018 Aug; 65(8):849-858. PubMed ID: 29877205
[TBL] [Abstract][Full Text] [Related]
9. Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women.
Hong SC; Yoo SW; Cho GJ; Kim T; Hur JY; Park YK; Lee KW; Kim SH
Menopause; 2007; 14(5):835-40. PubMed ID: 17667144
[TBL] [Abstract][Full Text] [Related]
10. Resistin and adiponectin levels in subjects with coronary artery disease and type 2 diabetes.
Yaturu S; Daberry RP; Rains J; Jain S
Cytokine; 2006 May; 34(3-4):219-23. PubMed ID: 16822679
[TBL] [Abstract][Full Text] [Related]
11. Hypothalamic-pituitary-adrenal axis dysfunction in critically ill patients with traumatic brain injury: incidence, pathophysiology, and relationship to vasopressor dependence and peripheral interleukin-6 levels.
Dimopoulou I; Tsagarakis S; Kouyialis AT; Roussou P; Assithianakis G; Christoforaki M; Ilias I; Sakas DE; Thalassinos N; Roussos C
Crit Care Med; 2004 Feb; 32(2):404-8. PubMed ID: 14758155
[TBL] [Abstract][Full Text] [Related]
12. The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship?
Muscogiuri G; Sorice GP; Prioletta A; Mezza T; Cipolla C; Salomone E; Giaccari A; Pontecorvi A; Della Casa S
Clin Endocrinol (Oxf); 2011 Mar; 74(3):300-5. PubMed ID: 21070314
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of GH reserve in patients with adrenal incidentalomas and biochemical evidence of subclinical autonomous glucocorticoid hypersecretion.
Tzanela M; Zianni D; Stylianidou Ch; Karavitaki N; Tsagarakis S; Thalassinos NC
Clin Endocrinol (Oxf); 2005 May; 62(5):597-602. PubMed ID: 15853831
[TBL] [Abstract][Full Text] [Related]
14. Plasma and urine levels of resistin and adiponectin in chronic kidney disease.
Yaturu S; Reddy RD; Rains J; Jain SK
Cytokine; 2007 Jan; 37(1):1-5. PubMed ID: 17383891
[TBL] [Abstract][Full Text] [Related]
15. Adrenocortical tumors: prevalence of impaired glucose tolerance and of "Paradoxical Rise" of cortisol during an oral glucose tolerance test.
Vierhapper H; Heinze G; Gessl A; Exner M
Exp Clin Endocrinol Diabetes; 2003 Oct; 111(7):415-20. PubMed ID: 14614648
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin--insulin and resistin plasma levels in young healthy offspring of patients with essential hypertension.
Papadopoulos DP; Makris TK; Perrea D; Papazachou O; Daskalaki M; Sanidas E; Votteas V
Blood Press; 2008; 17(1):50-4. PubMed ID: 18568692
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance, endocrine function and adipokines in type 2 diabetes patients at different glycaemic levels: potential impact for glucotoxicity in vivo.
Lindmark S; Burén J; Eriksson JW
Clin Endocrinol (Oxf); 2006 Sep; 65(3):301-9. PubMed ID: 16918948
[TBL] [Abstract][Full Text] [Related]
18. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
[TBL] [Abstract][Full Text] [Related]
19. Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese.
Wong VW; Wong GL; Yu J; Choi PC; Chan AW; Chan HY; Chu ES; Cheng AS; Chim AM; Chan FK; Sung JJ; Chan HL
Am J Gastroenterol; 2010 Jan; 105(1):132-8. PubMed ID: 19809411
[TBL] [Abstract][Full Text] [Related]
20. The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus.
Daniele G; Guardado Mendoza R; Winnier D; Fiorentino TV; Pengou Z; Cornell J; Andreozzi F; Jenkinson C; Cersosimo E; Federici M; Tripathy D; Folli F
Acta Diabetol; 2014 Feb; 51(1):123-31. PubMed ID: 24370923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
